abrdn plc Acquires New Holdings in Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS)
abrdn plc acquired a new stake in Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 552,572 shares of the biopharmaceutical company’s stock, valued at approximately $6,006,000. abrdn plc owned approximately 1.01% of Marinus Pharmaceuticals as of its most […]
More Stories
US Trade Deficit Narrows Sharply to Lowest Level Since 2009
By Andrew Moran The U.S. trade deficit narrowed sharply in October 2025, falling to its lowest level in 16 years,...
Vance Announces New Assistant AG Position to Tackle Fraud Nationwide
By Travis Gillmore Vice President JD Vance announced the creation of a new assistant attorney general position to help investigate...
What to Know About the New ‘Upside Down’ Food Pyramid
By Lawrence Wilson The Department of Agriculture has turned the familiar food pyramid upside down, significantly revising the dietary guidelines...
Buying—Not Invading—Greenland Gains Momentum in Congress
By Nathan Worcester WASHINGTON—After capturing Venezuela’s now-former leader, Nicolás Maduro, the Trump administration has renewed its talk of acquiring Greenland,...
US Nuclear Energy Industry Poised to Power Up, but Bottlenecks Loom
By John Haughey Ten companies are developing “first mover” nuclear energy innovations in breakneck bids to achieve “criticality” by July...
China Steps Up Cyberattacks on Taiwan’s Critical Infrastructure, Testing Wartime Readiness
By Michael Zhuang China has dramatically escalated cyberattacks against Taiwan’s critical infrastructure, launching an average of 2.63 million attacks per...